Lotrafiban
98%
- Product Code: 202777
CAS:
171049-14-2
| Molecular Weight: | 428.53 g./mol | Molecular Formula: | C₂₃H₃₂N₄O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Lotrafiban is a small molecule inhibitor that targets the glycoprotein IIb/IIIa receptor on platelets, which plays a critical role in blood clot formation. It is primarily used in the development and research of antiplatelet therapies aimed at preventing thrombotic events. Its application lies in the potential treatment of cardiovascular conditions such as acute coronary syndrome and during percutaneous coronary interventions (PCI), where preventing platelet aggregation is crucial. By blocking fibrinogen binding to platelets, Lotrafiban helps reduce the risk of arterial thrombosis. Although it has been studied in clinical trials, its use remains limited due to the emergence of more effective or safer antiplatelet agents. It continues to serve as a valuable tool in understanding platelet biology and drug development for cardiovascular diseases.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | $3,013.07 |
+
-
|
Lotrafiban
Lotrafiban is a small molecule inhibitor that targets the glycoprotein IIb/IIIa receptor on platelets, which plays a critical role in blood clot formation. It is primarily used in the development and research of antiplatelet therapies aimed at preventing thrombotic events. Its application lies in the potential treatment of cardiovascular conditions such as acute coronary syndrome and during percutaneous coronary interventions (PCI), where preventing platelet aggregation is crucial. By blocking fibrinogen binding to platelets, Lotrafiban helps reduce the risk of arterial thrombosis. Although it has been studied in clinical trials, its use remains limited due to the emergence of more effective or safer antiplatelet agents. It continues to serve as a valuable tool in understanding platelet biology and drug development for cardiovascular diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :